Patents For Sale


“System and Method for Medical Surveillance Through Personal Communication Device”

TransactionsIP LLC is pleased to present the exclusive patents for sale “System and method for medical surveillance through personal communication device” which includes two U.S. Granted Patent 10,861,601 B2 and 11,430,569 B2 and one U.S. patent applications 17/884,969 assigned to TOUCHDX Inc. The IP relates, in general, to enabling medical surveillance testing, assessing, and monitoring utilizing personal communication devices such as phones, smart watches and tablets. In particular aspects, the present invention provides a framework enabling seamless permission-based data collection and sharing between a primary app and third-party health & medical apps, for medical surveillance testing, assessing, monitoring, and processing of information.  Allowing for creation of apps that can collect, manage, and share medical, health and fitness data with the user’s permission.
The technology disclosed provides the following advantages:
  • Data Collection and Integration: Allows integration of third-party apps & devices to gather medical health and fitness data from various sources, including sensors on communication devices, wearable fitness trackers, and other connected health devices. It can aggregate data related to physical activity, heart rate, sleep patterns, nutrition, and more.
  • Centralized Data Repository: Acts as a centralized repository for all medical, health and fitness data on the user’s device. It provides a unified view of the user’s health information, making it easier for both users and developers to access and manage this data.
  • Privacy and Security: Ensures that users have control over their data and can choose which apps have access to it. Users/developers explicitly grant permission for apps to access data.

Knee Restraint System and Operating Room Clamp

TransactionsIP LLC is pleased to present the exclusive patents for sale Knee Restraint System And Surgical Bed Clampwhich includes U.S. Granted Patents US 10,709,596 B2; US 10,702,438 B1; US 8,689,793 B2; US 8,621,692 B1; US 8,561,234 B1 & US 8,051,515 B1 assigned to Ortho Biometrix LLC. The IP relates to devices for holding or securing a patient’s leg during knee arthroscopy surgery and any other medical procedures that requires immobilizing a patient’s leg and relates to a surgical bed and a clamp that attaches to the rail of a surgical bed.

OrthoBiometrix LLC’s  Knee Restraint System (KRS) or Knee Brace system is totally “unique” in the field of knee arthroscopy, which incorporate light weight, anatomical design, efficacy, and simplicity of use.

Manufacturer is Nylacarb of Vero Beach, Fl.   The company wholly owns the molds (a value of over U$ 250,000.00).  Current inventory is approximately 450 knee restraints and clamps.

Devices are available as both samples and surgical application, if required.  The KRS is currently in daily use by select surgeons, primarily Brett Casey, MD, Houma, La.

Key advantages of the KRS:

  • Easy to Set Up and Use.
  • Total access to Knee Joint, anatomical design.
  • Total weight less than 2 lbs.
  • Enhanced efficacy, safety, and comfort.
  • Facilitates sterile draping.
  • Promotes adjustability & control.
  • Provides support for distal thigh.
  • Allows manipulation & stressing of the knee joint during surgery.
  • Surgeon has complete control of varus & valgus stress application, facilitating access to knee joint.
  • Allows surgeon to sit during procedures.
  • Reduces need for additional surgical assistants.  The KRS could be considered a Surgical Assistant due to its salient advantages in the surgical suite.

To receive a Brokerage Marketing Package, please contact Rich Ehrlickman; [email protected]845-558-8300.

“Topical Treatments Incorporating Cannabis SP. Derived Botanical Drug Product” – 3 U.S. Patents & 1 U.S. Application

TransactionsIP LLC is pleased to Present these exclusive patents for sale “Topical Treatments Incorporating Cannabis SP. Derived Botanical Drug Product” which includes U.S. Granted Patents US 10226496, US 10653736, US 9095563 and US application 16/845,117 assigned to Ronald D. Sekura and Roscoe M. Moore.The IP relates to, a topical formulation consisting of an extract of cannabis sativa or cannabis indica.

The topical formulations covered by these patents provides the following advantages:

  • Analgesic, anti-inflammatory, anti-cancer, antibiotic, and antioxidant activity in treatment of dermatologic and other skin diseases.
  • As a hair care product they help in the removal of oils, dirt, skin particles, dandruff, environmental pollutants and other contaminant particles that gradually build up in hair.
  • The topical formulations are tailored and used to treat veterinary dermatoses including seborrhea, keratinization, ichthyosis, sebaceous adenitis, among other hair and dermatological disease occurring in animals.
  • The Cosmetic formulations including lotions, creams, soaps, shampoos, lip balms that are designed using CBD formulation are used for moisturizing, anti-aging, anti-wrinkle, acne treatment, rough skin treatment, and dandruff.

To receive a Brokerage Marketing Package, please contact Tom Major; [email protected], 480-231-6812.

“Endovascular & Extravascular Wireless Pacemaker System” – 6 U.S. Patents

TransactionsIP LLC is pleased to present the exclusive patents for sale Endovascular & Extravascular Wireless Pacemaker System” which includes U.S. Granted Patents US9216280, US9289593, US9775991, US10500394, US10549092 and US10821281All 6 Pacemaker Patents are Wireless, either Endovascular (within the vessels such as the Coronary Sinus) or Extravascular (outside the vascular System) such as within the Intercoastal Space.

The technology disclosed provides the following advantages:

  • The only extra vascular wireless intercostal pacemaker defibrillator generator and lead.
  • The only pacemaker defibrillator algorithm that incorporates non-electric input such as body position, Doppler blood flow and echocardiographic wall motion. 
  • The only wireless coronary sinus pacemaker/ defibrillator that incorporates one or more right atrial leads, one or more left atrial leads, and one or more left ventricular leads in one structure.
  • The only wireless pacemaker lead that is not rod shaped but flat ribbon-like that hugs the inner contour of the coronary venous system.
  • The only wireless intercostal pacemaker that can pace the heart using ultrasound energy.
  • The only intercostal pacemaker generator that is rechargeable.
  • The only wireless device that provides atrial and left ventricular pacing in one structure within the coronary venous system. 
  • The only wireless lead that discloses an electric conduit that bypasses the AV node with controlled rate and direction of conduction without the need for a battery.

To receive a Brokerage Marketing Package, please contact Rich Ehrlickman; [email protected]845-558-8300.